Long-Acting ADHD Meds for Anxious Adult Patients
When choosing the right treatment for depression or anxiety, patients often weigh the benefits and side effects of different medications. Both of these selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed and have proven effective for mood disorders. The choice between Zoloft vs Lexapro can depend on individual response, side effects, or coexisting conditions. While one may work better for generalized anxiety, the other might be preferred for major depression. Consulting a healthcare provider is essential to determine which medication suits each person's unique needs, as both options offer relief but may differ in tolerability and onset of action.
ADHD and anxiety disorders often co-occur in adults. In fact, it's estimated that nearly 50% of adults with ADHD also experience an anxiety disorder. These conditions can amplify one another: the inattention and disorganization caused by ADHD may increase stress levels, while anxiety can worsen the ability to focus and complete tasks. Treating both conditions at once can be challenging, especially when using stimulant medications, which can sometimes increase anxiety symptoms. Therefore, choosing the right treatment is crucial to ensuring balanced mental health.
Long-acting ADHD medications offer several benefits for anxious adult patients. Unlike short-acting versions, which may wear off in a few hours and cause a crash in mood or energy, long-acting medications provide a smoother, extended release of active ingredients. This consistent delivery helps reduce the peaks and valleys that can trigger anxiety or mood disturbances. For adults who work full-time or have complex daily responsibilities, these medications can maintain focus, organization, and emotional regulation throughout the day without the need for multiple doses.
There are several long-acting ADHD medications available, many of which are formulated to release their active ingredient slowly over time. Commonly prescribed long-acting stimulants include Concerta (methylphenidate), Adderall XR (amphetamine salts), Vyvanse (lisdexamfetamine), and Focalin XR (dexmethylphenidate). These medications can be effective for up to 10 to 14 hours, providing full-day symptom management. For patients sensitive to stimulants or prone to anxiety, non-stimulant options like Strattera (atomoxetine) or Qelbree (viloxazine) may be preferred, as they are less likely to increase nervousness or jitteriness.
Vyvanse is a widely used long-acting stimulant that is often well-tolerated by anxious patients. Its mechanism of action involves the gradual conversion of the prodrug lisdexamfetamine into its active form, which leads to a more predictable and sustained effect. This gradual release can reduce the risk of a sudden onset of stimulant side effects such as irritability or restlessness. Because it has a lower potential for abuse and misuse, it's also considered a safer choice for long-term treatment in adults with a history of anxiety or mood instability.
Strattera, or atomoxetine, is a non-stimulant medication approved for ADHD treatment in both children and adults. For anxious patients, Strattera can be particularly beneficial because it doesn't carry the same risk of increasing anxiety as stimulant medications might. It works by selectively inhibiting the reuptake of norepinephrine, which can help improve focus and attention without inducing the overstimulation that sometimes exacerbates anxiety. It typically takes several weeks to reach full effectiveness, but the trade-off may be worth it for those who need a gentler approach to symptom control.
Qelbree (viloxazine) is a newer non-stimulant ADHD medication that has shown promise in managing symptoms in adults. Early studies suggest that it can help with inattention and hyperactivity without significantly raising anxiety levels. Its once-daily dosing and extended-release profile make it a convenient option for busy adults. Although it is not yet as commonly prescribed as other long-acting medications, Qelbree may become a go-to choice for patients who are unable to tolerate stimulants or who have significant comorbid anxiety.
Treating adults with both ADHD and anxiety requires a nuanced approach. While stimulant medications are the most effective for core ADHD symptoms, they must be used cautiously in those prone to anxiety. Clinicians often start with lower doses and gradually increase as needed, closely monitoring anxiety levels. In some cases, a combination of medications may be necessary—such as using a long-acting stimulant alongside an anti-anxiety medication or antidepressant. Non-pharmacologic interventions like cognitive-behavioral therapy (CBT) also play a key role in comprehensive care.
Although long-acting ADHD medications are generally well-tolerated, they can still cause side effects, especially in sensitive individuals. Common side effects include insomnia, appetite suppression, elevated heart rate, and increased anxiety. Regular follow-up with a healthcare provider is important to monitor for these issues and adjust the dosage or medication as needed. Patients are encouraged to keep a symptom journal to track their response and communicate any concerns with their doctor.
Long-acting ADHD medications offer a valuable option for adults dealing with both ADHD and anxiety. With their stable release mechanisms and all-day symptom control, they can help patients achieve better focus and emotional balance without the frequent dosing or mood swings associated with short-acting options. Whether through stimulant or non-stimulant medications, personalized treatment plans that consider anxiety symptoms can make a significant difference in daily functioning and overall quality of life. As always, working closely with a knowledgeable healthcare provider is essential to finding the most effective and tolerable medication strategy.
TIME BUSINESS NEWS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
US FDA advisers vote against Otsuka's PTSD combination treatment
(Reuters) -The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's drug when used in combination with Viatris' Zoloft for the treatment of adults with PTSD. The panel voted 10-1 to say the available data does not establish the efficacy of the drug, brexpiprazole, in combination with Zoloft for treating the condition. PTSD, a disorder caused by very stressful events, affects about 4% of U.S. adults and is commonly associated with war veterans. But natural disasters, abuse or other trauma may also trigger the condition in civilians. The recommendation comes after the FDA's staff reviewers on Wednesday raised efficacy concerns over the use of the combination therapy, citing inconsistent trial results and a modest treatment effect. Solve the daily Crossword
Fast Company
2 days ago
- Fast Company
What every manager should know about ADHD
If you ask a doctor about ADHD, they will tell you that it's a developmental disorder characterized by traits of forgetfulness, impulsivity, and disorganization. However, there are so many great qualities associated with ADHD that don't get discussed, just some of which include creativity, resilience, problem-solving, and hyper focus. Neurodivergent people are the world's best problem-solvers. We have had to practice it for our entire lives. From a very young age we have had to find unique solutions to really difficult problems because we are intrinsically a little bit different. We are also great at reading other people. We can hyper focus on people's micro communications, pick up on tiny fluctuations in tone of voice, and little changes in facial expressions that neurotypical people miss. We can recognize patterns in people's mannerisms, which enables us to judge someone's character extremely effectively. Rejection Sensitivity Dysphoria People with ADHD people are criticised around 20,000 more times than your average child. We have heard things like, 'why are you being lazy,' 'stop fidgeting,' and 'be normal.' This means that as adults we are often more sensitive to rejection, and might experience something called Rejection Sensitive Dysphoria, which causes intense pain triggered by real or perceived rejection. For example, if you don't explicitly invite an ADHD person to a social event, we will assume you don't actually want us there. If you say, 'come if you want,' we will think that our presence at that social event is a nuisance, and might even think you hate us as well. Similarly, if you don't tell someone with ADHD that you explicitly like them, we will assume that you tolerate us. And as a manager, if you ask an ADHD person for a quick chat, we might assume you want a quick chat so you can fire us. Carefully consider your wording and make sure to balance any feedback with positive comments. Be explicit and intentional when sending invitations to work events and briefly explain what any quick chats will cover. Integrating regular breaks When RSD hits us, it hits hard. We might need a minute to remove ourselves from any situation, whether that's going to get some fresh air, or pacing up and down the street for a while. Allowing for breaks and not questioning it will help put space between the stimulus and reaction, allowing our brain time to regulate itself again and not be influenced by intense feelings. The pause also allows us to practise self-compassion and not react impulsively in the moment. If someone asks for a minute, it might be the break they need to return back fully focussed. Burnout and vulnerability It's common for ADHD employees to overwork, stay up late into the night, and push ourselves to the limit. They have spent their whole lives feeling as if they're not good enough, so it's no surprise they might feel like they have something to prove. The early warning signs are unique to all of us and we all need to be aware of our own, but it's sometimes possible to spot it in other people as well. Some of these early signs might include: becoming easily agitated, forgetting things that would usually be remembered, becoming less patient, and neglecting self-care. One way leaders can help is by creating culture of psychological safety, where your employees feel able to speak out if they are struggling. If your culture is about purely celebrating wins then you are not really creating an environment where other people feel safe to ask for help if they need it. It's important to set the tone from above that it's okay to be vulnerable and speak out about anything that might be causing stress—whether it's social interactions, difficulties with tasks, or deadline difficulties. Remember that everyone is unique Many leaders think that a blanket accommodations policy will be beneficial to everyone. You often see companies say that they will integrate movement breaks, adopt flexible working, and normalize fidget toys and noise-cancelling headphones. These are great, but leaders need to recognize that everyone has a brain as unique as their fingerprint, and everyone's needs will be different. It's more important to create a culture of psychological safety, where people feel empowered to speak up and ask for the specific support they need to perform their job well.
Axios
3 days ago
- Axios
Brigham, IBM's AI tool could help warn Boston's hottest neighborhoods of heat waves
While a heat wave smothers Boston, researchers are developing a tool to warn people of heat emergencies and the risks they face sooner. Why it matters: Some Boston neighborhoods — known as "urban heat islands" — are scorching by the time the sensor at Logan Airport notifies forecasters and city leaders of a heat emergency. Driving the news: A team at Brigham and Women's Hospital and IBM is building an AI-driven tool that would identify high temperatures in urban heat islands sooner and offer suggestions on how to cool down. That could mean going to a cooling center or an air-conditioned library building nearby, says Paul Biddinger, chief preparedness and continuity officer at Mass General Brigham, who is leading the project. The team envisions the tool warning community health center patients of heat emergencies, especially those who may be at high risk, without compromising sensitive health data. What they're saying: "People don't know when they're at higher risk often," Biddinger tells Axios. Take water pills for heart failure? Got chronic lung or kidney conditions? You're at higher risk, Biddinger wrote Tuesday. Take SSRIs for depression? You, too. Zoom out: The coastal Northeast is heating faster than most regions in North America, per UMass research. But many homes lack updated infrastructure or were designed to trap heat to keep residents warm in the winter. More people will become vulnerable to extreme heat risks as climate change worsens, doctors and researchers say. Threat level: The state estimated last year that at least 30 people have died from extreme heat here in the past decade, and that doesn't take into account the thousands who have been hospitalized since 2000. Pockets of Dorchester, South Boston, Chinatown and Roxbury see higher temperatures than neighboring areas. Yes, but: The AI tool is still in development, Biddinger says. The team plans to launch a prototype in multiple languages before next summer and a final version by 2027. Reality check: In the meantime, Bostonians will have to take the forecast with a grain of salt (or round up the temperature), depending on where they live.
